IDS gene

Last updated on: 01.08.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The IDS gene (IDS stands for: iduronate 2-sulfatase) is a protein-coding gene localized on Xq28. Alternative splicing leads to several transcript variants, at least one of which codes for a preprotein that is proteolytically processed. An important paralog of this gene is ARSD.

General informationThis section has been translated automatically.

The IDS gene encodes a member of the sulfatase family of proteins. The encoded preprotein is proteolytically processed to produce two polypeptide chains. The encoded sulfatase is involved in the lysosomal degradation of heparan sulfate and dermatan sulfate.

Mutations in this gene are associated with the X-linked lysosomal storage disease mucopolysaccharidosis type II, also known as Hunter syndrome. Blaschko-linear hyperpigmentation associated with mucopolysaccharidosis type II (Sofronova V et al. 2023) and Mongolian spots have been described

Clinical pictureThis section has been translated automatically.

Mucopolysaccharidosis type II (MPS II) is a rare, progressive and ultimately fatal X-linked lysosomal storage disorder caused by mutations in the iduronate-2-sulfatase (IDS) gene.

In a larger (n=130) Chinese cohort with MPS II, the following symptoms were found (Zhang Z et al.2023):

  • claw-like hands
  • coarse facial features
  • birthmarks (Mongolian spot)
  • developmental delays
  • Inguinal or umbilical hernias.
  • Cardiac manifestations:
    • Mitral/tricuspid valve regurgitation (71.9 %)
    • Aortic/pulmonary valve regurgitation (36.8 %).

To date, 43 different IDS-pathogenic gene variants have been identified. The variants were concentrated in exon 9 (20% = 11/55), exon 3 (20% = 11/55) and exon 8 (15% = 8/55).

LiteratureThis section has been translated automatically.

  1. Sofronova V et al. (2023) A Case of Mucopolysaccharidosis II Caused by a Novel Variant with Skin Linear Hyperpigmented Streaks along Blaschko's Lines. Int J Mol Sci 24:5647.
  2. Zhang Z et al.(2023) Phenotypic and genetic characteristics of 130 patients with mucopolysaccharidosis type II: A single-center retrospective study in China. Front Genet 14:1103620.

Last updated on: 01.08.2024